Pigmented Basal Cell Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Bone neoplasms
|
group |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
151
|
4
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Testicular Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
124
|
31
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Secretory meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Angioblastic Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
219
|
7
|
0.300 |
None |
|
0 |
|
|
|
Renal cell carcinoma, usually clear cell type
|
phenotype |
Neoplasms
|
Finding
|
1
|
|
0.300 |
strong |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Hematopoetic Myelodysplasia
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
38
|
|
0.200 |
None |
|
0 |
|
|
|
Neoplastic Syndromes, Hereditary
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
88
|
6387
|
0.180 |
None |
1.000 |
19 |
23
|
2011 |
2019 |
CUI: |
C0027960 |
Disease: |
Nevus
|
Nevus
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
43
|
0.150 |
None |
1.000 |
5 |
|
2013 |
2016 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.964 |
167 |
1
|
1998 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.986 |
72 |
1
|
2011 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.950 |
40 |
|
2010 |
2019 |
Malignant Pleural Mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
421
|
15
|
0.100 |
None |
1.000 |
34 |
|
2011 |
2020 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2078
|
990
|
0.100 |
None |
1.000 |
21 |
|
1999 |
2019 |
Monosomy
|
group |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
214
|
11
|
0.100 |
None |
0.917 |
12 |
|
2012 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.909 |
11 |
|
2014 |
2019 |
BAP1 tumor predisposition syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
1
|
|
0.100 |
None |
1.000 |
11 |
|
2015 |
2019 |
Malignant Mesothelioma of Peritoneum
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
65
|
2
|
0.100 |
None |
1.000 |
10 |
|
2015 |
2020 |
Inflammatory abnormality of the eye
|
disease |
|
Disease or Syndrome
|
88
|
1
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the lymphatic system
|
disease |
|
Anatomical Abnormality
|
16
|
|
0.100 |
None |
|
0 |
|
|
|
Dry Skin, CTCAE
|
phenotype |
|
Finding
|
137
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of refraction
|
disease |
|
Anatomical Abnormality
|
28
|
31
|
0.100 |
None |
|
0 |
|
|
|
Abnormal visual accommodation
|
phenotype |
|
Pathologic Function
|
5
|
|
0.100 |
None |
|
0 |
|
|
|